Showing results (101-110 of 518) with videos related to
Sort By:
Pageof 52
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumoursM Rodolfo, C Bassi, C Salvi, et al.International Journal of Cancer|April 1, 1994
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profilesC Maccalli, R Mortarini, G Parmiani, et al.Cancer Research|November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cellsG Pietra, R Mortarini, G Parmiani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Vaccination of patients with solid tumoursG Parmiani, L Pilla, C Castelli, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicinR Supino, M Mariani, E Prosperi, et al.International Journal of Cancer|February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinationsR Mortarini, F Belli, G Parmiani, et al.International Journal of Cancer|December 15, 1990
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicityM Sensi, M Bergomi, F Formelli, et al.Melanoma Research|July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?G Parmiani, A Anichini, G Carbone, et al.Journal of Immunogenetics|April 1, 1977
Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcomaG Invernizzi, G Carbone, A Meschini, et al.Neurosurgery|June 1, 1994
Successful adoptive immunotherapy with lymphokine-activated killer cells in the treatment of medulloblastoma disseminated via cerebrospinal fluid: case reportA Silvani, A Salmaggi, G Parmiani, et al.Pageof 52